Koichi Node

Q: What Schools Are Affiliated With Koichi Node

Koichi Node is affiliated with the following schools: Kagoshima University, Hiroshima University, University of Marburg, Tokai University, Tokyo University of Pharmacy and Life Sciences, University of Tokyo, Showa University, Institute of Science Tokyo, Saga University, Osaka University, Kyoto University

Koichi Node's AcademicInfluence.com Rankings

Koichi Node

Computer Science

#6648

World Rank

#7007

Historical Rank

Computational Linguistics

#1190

World Rank

#1204

Historical Rank

Machine Learning

#2228

World Rank

#2256

Historical Rank

Artificial Intelligence

#2498

World Rank

#2539

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Koichi Node's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science University of Tokyo
Bachelors Computer Science University of Tokyo

Similar Degrees You Can Earn

Why Is Koichi Node Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Koichi Node's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. (1999) (1133)
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014) (2014) (1031)
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy (2002) (746)
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. (2001) (517)
Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy (2003) (435)
3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27 Kip1 * (1999) (418)
Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. (2011) (389)
JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure　- Digest Version. (2019) (293)
Comparison of Serum High–Molecular Weight (HMW) Adiponectin With Total Adiponectin Concentrations in Type 2 Diabetic Patients With Coronary Artery Disease Using a Novel Enzyme-Linked Immunosorbent Assay to Detect HMW Adiponectin (2006) (264)
Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2 (2004) (250)
Activation of Gαs Mediates Induction of Tissue-type Plasminogen Activator Gene Transcription by Epoxyeicosatrienoic Acids* (2001) (242)
Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. (2010) (229)
Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae (2015) (222)
Endothelial dysfunction as a cellular mechanism for vascular failure. (2012) (208)
The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension (2009) (199)
Plasma adenosine levels increase in patients with chronic heart failure. (1997) (194)
Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: role of nitric oxide and calcium-activated potassium channels. (1997) (192)
Molecular basis of restenosis and novel issues of drug-eluting stents. (2009) (173)
Mobilization of CD34-Positive Bone Marrow–Derived Cells After Coronary Stent Implantation: Impact on Restenosis (2007) (172)
The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells. (2012) (166)
Noninvasive method for assessing the human circadian clock using hair follicle cells (2010) (160)
Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. (2005) (158)
Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. (1997) (151)
Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. (2006) (149)
High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. (2014) (147)
Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase. (1996) (141)
Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. (2008) (134)
Postprandial hyperglycemia as an etiological factor in vascular failure (2009) (134)
Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation. (2002) (133)
Physiological Diagnostic Criteria for Vascular Failure. (2018) (132)
Mitochondrial Dysfunction and Increased Reactive Oxygen Species Impair Insulin Secretion in Sphingomyelin Synthase 1-null Mice* (2010) (130)
High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. (2007) (123)
Involvement of the Protein Kinase CK2 in the Regulation of Mammalian Circadian Rhythms (2009) (116)
Simvastatin Decreases IL-6 and IL-8 Production in Epithelial Cells (2006) (113)
Protein Kinase A as Another Mediator of Ischemic Preconditioning Independent of Protein Kinase C (2004) (107)
Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes (2014) (106)
Cardioprotective Effect Afforded by Transient Exposure to Phosphodiesterase III Inhibitors: The Role of Protein Kinase A and p38 Mitogen-Activated Protein Kinase (2001) (105)
Flow-Mediated Vasodilation as a Diagnostic Modality for Vascular Failure (2008) (102)
α1-Adrenoceptor Activation Increases Ecto-5′-Nucleotidase Activity and Adenosine Release in Rat Cardiomyocytes by Activating Protein Kinase C (1995) (101)
Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers. (2006) (93)
Tropical fruit camu-camu (Myrciaria dubia) has anti-oxidative and anti-inflammatory properties. (2008) (93)
Optimal Windows of Statin Use for Immediate Infarct Limitation: 5′-Nucleotidase as Another Downstream Molecule of Phosphatidylinositol 3-Kinase (2004) (93)
Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. (1995) (88)
Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart. (2001) (88)
Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening. (2008) (87)
Temporary acidosis during reperfusion limits myocardial infarct size in dogs. (1997) (86)
Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart disease. (2016) (85)
Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients. (2005) (83)
Role of Phasic Dynamism of p38 Mitogen-Activated Protein Kinase Activation in Ischemic Preconditioning of the Canine Heart (2001) (79)
Vascular failure: a new clinical entity for vascular disease (2006) (78)
Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. (1996) (78)
The role of the endocrine system in feeding-induced tissue-specific circadian entrainment. (2014) (77)
Evidence for nitric oxide generation in the cardiomyocytes: its augmentation by hypoxia. (1995) (77)
Continuous Positive Airway Pressure Therapy Improves Vascular Dysfunction and Decreases Oxidative Stress in Patients With the Metabolic Syndrome and Obstructive Sleep Apnea Syndrome (2012) (76)
Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study. (2007) (72)
Adenosine and cardioprotection in the diseased heart. (1999) (72)
Opening of Ca2+-activated K+ channels is involved in ischemic preconditioning in canine hearts. (2004) (72)
A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs. (1999) (71)
Prognostic value of pentraxin 3 in patients with chronic heart failure. (2008) (69)
Plasma nitric oxide end products are increased in the ischemic canine heart. (1995) (69)
Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. (1997) (69)
Long-Acting Ca2+ Blockers Prevent Myocardial Remodeling Induced by Chronic NO Inhibition in Rats (2003) (68)
Uric acid and cardiovascular disease: A clinical review. (2020) (66)
Endothelial Dysfunction, Increased Arterial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary Artery Disease: FMD‐J (Flow‐Mediated Dilation Japan) Study A (2018) (64)
Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study (2010) (60)
Association of -786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance (2002) (60)
Azelnidipine Reduces Urinary Protein Excretion and Urinary Liver-Type Fatty Acid Binding Protein in Patients with Hypertensive Chronic Kidney Disease (2007) (58)
Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. (2004) (58)
Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension (2013) (57)
Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism (2017) (56)
Bradykinin mediation of Ca(2+)-activated K+ channels regulates coronary blood flow in ischemic myocardium. (1997) (56)
Role of intracellular Ca2+ in activation of protein kinase C during ischemic preconditioning. (1997) (56)
The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial (2016) (56)
Reliability of measurement of endothelial function across multiple institutions and establishment of reference values in Japanese. (2015) (55)
Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease. (2008) (54)
Role of protein kinase C-alpha in activation of ecto-5'-nucleotidase in the preconditioned canine myocardium. (1997) (54)
A multicenter study design to assess the clinical usefulness of semi-automatic measurement of flow-mediated vasodilatation of the brachial artery. (2012) (54)
Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice. (2013) (53)
Role of nitric oxide in regulation of coronary blood flow during myocardial ischemia in dogs. (1996) (52)
Mitogen-Activated Protein Kinase Is a Functional Component of the Autonomous Circadian System in the Suprachiasmatic Nucleus (2008) (52)
levation of Plasma Adenosine Levels May Attenuate the Severity of Chronic Heart Failure (1998) (51)
Pentraxin-3 regulates the inflammatory activity of macrophages (2016) (49)
A positive role for PERIOD in mammalian circadian gene expression. (2014) (49)
Longitudinal association among endothelial function, arterial stiffness and subclinical organ damage in hypertension. (2018) (49)
EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in mice. (2017) (49)
Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells (2015) (47)
Effect of Exercise Therapy on Monocyte and Neutrophil Counts in Overweight Women (2010) (47)
Role of activation of ectosolic 5'-nucleotidase in the cardioprotection mediated by opening of K+c channels. (1996) (46)
Angiotensin II induces microtubule reorganization mediated by a deacetylase SIRT2 in endothelial cells (2011) (45)
Effects of sitagliptin beyond glycemic control: focus on quality of life (2013) (45)
β-Adrenoceptor Blocker Carvedilol Provides Cardioprotection via an Adenosine-Dependent Mechanism in Ischemic Canine Hearts (2004) (44)
Differential Subcellular Actions of ACE Inhibitors and AT1 Receptor Antagonists on Cardiac Remodeling Induced by Chronic Inhibition of NO Synthesis in Rats (2001) (44)
Simvastatin Stimulates Vascular Endothelial Growth Factor Production by Hypoxia-inducible Factor-1α Upregulation in Endothelial Cells (2008) (43)
Inhibition of nitric oxide synthesis increases adenosine production via an extracellular pathway through activation of protein kinase C. (1997) (43)
Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study (2017) (42)
Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE) (2020) (42)
Eicosapentaenoic Acid Reduces Myocardial Injury Induced by Ischemia and Reperfusion in Rabbit Hearts (2003) (40)
Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening (2005) (40)
Establishment of a quantitative, qualitative, and high-throughput analysis of sulfatides from small amounts of sera by matrix-assisted laser desorption ionization-time of flight mass spectrometry. (2007) (40)
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial (2016) (40)
Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure (2007) (39)
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial (2020) (39)
Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase. (2002) (38)
Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity. (1996) (38)
Diagnostic Criteria of Flow‐Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin‐Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery (2020) (38)
Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study (2018) (38)
Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubes (2019) (38)
Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial (2019) (38)
The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure: home telemonitoring study for patients with heart failure (HOMES-HF) (2018) (38)
Comparison of Renal and Vascular Protective Effects between Telmisartan and Amlodipine in Hypertensive Patients with Chronic Kidney Disease with Mild Renal Insufficiency (2008) (38)
Increased Oxidative Stress Impairs Adipose Tissue Function in Sphingomyelin Synthase 1 Null Mice (2013) (38)
Activation of ecto‐5′‐nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart (1997) (38)
Raloxifene Prevents Cardiac Hypertrophy and Dysfunction in Pressure-Overloaded Mice (2004) (37)
Effect of acute dynamic exercise on circulating plasma nitric oxide level and correlation to norepinephrine release in normal subjects. (1997) (37)
Systemic hemodynamic atherothrombotic syndrome (SHATS) - Coupling vascular disease and blood pressure variability: Proposed concept from pulse of Asia. (2019) (37)
Marked cerebral atrophy is correlated with kidney dysfunction in nondisabled adults (2010) (36)
Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure. (1998) (36)
Anti-Inflammatory Properties of Azelnidipine, a Dihydropyridine-Based Calcium Channel Blocker (2010) (35)
Reversible primary hypothyroidism in Japanese patients undergoing maintenance hemodialysis. (2008) (34)
Evaluation of serial changes in tissue characteristics during statin-induced plaque regression using virtual histology-intravascular ultrasound studies. (2013) (34)
Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit? (2017) (34)
IL-13 attenuates vascular tube formation via JAK2-STAT6 pathway. (2008) (34)
Effects of pitavastatin in Japanese patients with chronic heart failure: the Pitavastatin Heart Failure Study (PEARL Study). (2013) (34)
The relationship between neutrophil to lymphocyte ratio, endothelial function, and severity in patients with obstructive sleep apnea. (2016) (34)
Methotrexate and MX-68, a New Derivative of Methotrexate, Limit Infarct Size via Adenosine-Dependent Mechanisms in Canine Hearts (2004) (33)
Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes. (2008) (33)
Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy. (2007) (33)
Angiotensin II Increases Expression of IP-10 and the Renin-Angiotensin System in Endothelial Cells (2008) (33)
Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury. (1998) (32)
Effect of Pitavastatin on Urinary Liver-Type Fatty-Acid-Binding Protein in Patients with Nondiabetic Mild Chronic Kidney Disease (2006) (32)
Selective blockade of serotonin 5-HT2A receptor increases coronary blood flow via augmented cardiac nitric oxide release through 5-HT1B receptor in hypoperfused canine hearts. (2004) (32)
A Polymorphism Regulates CYP4A11 Transcriptional Activity and Is Associated With Hypertension in a Japanese Population (2008) (32)
Deletion of Apoptosis Inhibitor of Macrophage (AIM)/CD5L Attenuates the Inflammatory Response and Infarct Size in Acute Myocardial Infarction (2016) (32)
Low serum albumin level is risk factor for patients with percutaneous endoscopic gastrostomy. (2010) (32)
Emerging roles of sodium-glucose cotransporter 2 inhibitors in cardiology. (2017) (31)
Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus. (2007) (31)
Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial) (2016) (31)
Activation of protein kinase C increases adenosine production in the hypoxic canine coronary artery through the extracellular pathway. (1995) (31)
Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure (2013) (31)
Effects of uric acid on vascular endothelial function from bedside to bench (2018) (30)
Do incretins improve endothelial function? (2014) (30)
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial (2017) (30)
Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report (2014) (30)
Activation of ecto-5'-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. (1996) (29)
Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation (2021) (29)
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study (2016) (29)
IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice. (2011) (29)
Role of cellular acidosis in production of nitric oxide in canine ischemic myocardium. (2001) (29)
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure. (2021) (29)
Effects of aerobic exercise on lipid profiles and high molecular weight adiponectin in Japanese workers. (2011) (28)
Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium. (1998) (28)
Statin Therapy for Vascular Failure (2007) (28)
Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version (2013) (27)
Varenicline-assisted smoking cessation decreases oxidative stress and restores endothelial function (2014) (27)
Increased interleukin-13 levels in patients with chronic heart failure. (2009) (26)
Eicosapentaenoic acid increases cytochrome P-450 2J2 gene expression and epoxyeicosatrienoic acid production via peroxisome proliferator-activated receptor γ in endothelial cells. (2009) (25)
High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: The Standard versus high-dose therApy with Rosuvastatin for lipiD lowering (SARD) trial. (2016) (25)
Association between high molecular weight adiponectin levels and metabolic parameters. (2009) (25)
JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases. (2021) (25)
[Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart]. (2002) (25)
Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation. (2008) (25)
Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice. (2013) (25)
Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor (2015) (25)
Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version (2013) (24)
Benefits and limitations of cypher stent-based bifurcation approaches: in vitro evaluation using micro-focus CT scan. (2009) (24)
Compensation for intracellular environment in expression levels of mammalian circadian clock genes (2014) (24)
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure. (2021) (24)
Bipolar Voltage Mapping for the Evaluation of Atrial Substrate: Can We Overcome the Challenge of Directionality? (2019) (24)
Impaired glucose tolerance: a possible contributor to left ventricular hypertrophy and diastolic dysfunction. (2007) (24)
Effects of Statins on Restenosis After Coronary Stent Implantation (2007) (23)
Nifedipine limits infarct size via NO-dependent mechanisms in dogs (2001) (23)
α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study (2017) (23)
Increased release of nitric oxide in ischemic hearts after exercise in patients with effort angina. (1998) (23)
The lncRNA Caren antagonizes heart failure by inactivating DNA damage response and activating mitochondrial biogenesis (2021) (23)
Bright light improves sleep in patients with Parkinson’s disease: possible role of circadian restoration (2020) (23)
Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study (2016) (23)
Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: role of bradykinin and nitric oxide. (2000) (23)
Current status of long-term prognosis among all subtypes of pulmonary hypertension in Japan. (2019) (22)
Brachial artery diameter as a marker for cardiovascular risk assessment: FMD-J study. (2018) (22)
Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart. (2002) (22)
Raloxifene Improves Coronary Perfusion, Cardiac Contractility, and Myocardial Metabolism in the Ischemic Heart: Role of Phosphatidylinositol 3-Kinase/Akt Pathway (2004) (22)
Effect of insulin-unstimulated diabetic therapy with miglitol on serum cystatin C level and its clinical significance. (2009) (21)
Endothelial Function Is Impaired in Patients Receiving Antihypertensive Drug Treatment Regardless of Blood Pressure Level: FMD-J Study (Flow-Mediated Dilation Japan) (2017) (21)
Effects of Candesartan for Middle-Aged and Elderly Women with Hypertension and Menopausal-Like Symptoms (2006) (21)
Atorvastatin inhibits angiotensin II-induced T-type Ca2+ channel expression in endothelial cells. (2006) (21)
Alternative spliced variants in the pantetheinase family of genes expressed in human neutrophils. (2008) (21)
Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial (2018) (21)
Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension. (2018) (20)
The Mammalian Circadian Clock Protein Period Counteracts Cryptochrome in Phosphorylation Dynamics of Circadian Locomotor Output Cycles Kaput (CLOCK)* (2014) (20)
Correction: Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae (2015) (20)
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin. (2002) (20)
An out-of-lab trial: a case example for the effect of intensive exercise on rhythms of human clock gene expression (2013) (20)
Coronavirus Disease 2019 (COVID-19) Information for Cardiologists　- Systematic Literature Review and Additional Analysis. (2020) (20)
Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure. (2019) (19)
Low-Density Lipoprotein Subfractions and the Prevalence of Silent Lacunar Infarction in Subjects with Essential Hypertension (2006) (19)
Marked increase of insulin gene transcription by suppression of the Rho/Rho-kinase pathway. (2006) (19)
Associations of monocytes, neutrophil count, and C-reactive protein with maximal oxygen uptake in overweight women. (2008) (19)
Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome. (2008) (19)
Gut microbiota and hypertension (2019) (19)
Rab5a-mediated localization of claudin-1 is regulated by proteasomes in endothelial cells. (2011) (19)
Estimated glomerular filtration rate as a predictor of secondary outcomes in Japanese patients with coronary artery disease. (2009) (18)
2-Cl-C.OXT-A stimulates contraction through the suppression of phosphodiesterase activity in human induced pluripotent stem cell-derived cardiac organoids (2019) (18)
The role of vascular failure in coronary artery spasm. (2011) (18)
Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials (2018) (18)
Association between N-terminal pro B-type natriuretic peptide and day-to-day blood pressure and heart rate variability in a general population: the Ohasama study (2015) (18)
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study (2020) (18)
Long-term effects of AST-120 on the progression and prognosis of pre-dialysis chronic kidney disease: a 5-year retrospective study (2016) (18)
The role of estrogen and estrogen-related drugs in cardiovascular diseases. (2003) (17)
Myeloid-related protein-8/14 in acute coronary syndrome. (2017) (17)
Activation of Ecto-5′-nucleotidase and cardioprotection by ischemic preconditioning (1996) (17)
Clinical significance of non-slip element balloon angioplasty for patients of coronary artery disease: a preliminary report. (2014) (17)
AICA riboside improves myocardial ischemia in coronary microembolization in dogs. (1994) (17)
Benidipine, a Long-acting Ca Channel Blocker, Limits Infarct Size via Bradykinin- and NO-Dependent Mechanisms in Canine Hearts (2004) (17)
Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation (2006) (16)
Bidirectional effects of aminophylline on myocardial ischemia. (1995) (16)
In vivo evaluation of the effect of lithium on peripheral circadian clocks by real-time monitoring of clock gene expression in near-freely moving mice (2019) (16)
Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study (2016) (16)
A promising culture model for analyzing the interaction between adipose tissue and cardiomyocytes. (2011) (16)
Association of Body Mass Index with Ischemic and Hemorrhagic Stroke (2021) (16)
STAT6 Mediates Apoptosis of Human Coronary Arterial Endothelial Cells by Interleukin-13 (2008) (16)
Impact of Obstructive Sleep Apnoea on Heart Failure with Preserved Ejection Fraction. (2016) (16)
The late-phase inflammatory response after drug-eluting stent implantation (2014) (16)
Renovascular protective effects of erythropoietin in patients with chronic kidney disease. (2011) (16)
Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors. (2021) (15)
Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With Coronary Artery Disease　- Post Hoc Analysis of the FMD-J Study A. (2019) (15)
The Japanese Society of Hypertension—Digest of plan for the future (2018) (15)
Repetitive hyperthermia attenuates progression of left ventricular hypertrophy and increases telomerase activity in hypertensive rats. (2012) (15)
Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial (2021) (15)
Adenosine inhibits leukocyte-induced vasoconstriction. (1996) (15)
Activation of matrix metalloproteinase-9 is associated with mobilization of bone marrow-derived cells after coronary stent implantation. (2011) (15)
Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study (2016) (15)
Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart. (1997) (15)
Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET). (2011) (14)
Estimation methods for human circadian phase by use of peripheral tissues (2016) (14)
Celiprolol Increases Coronary Blood Flow and Reduces Severity of Myocardial Ischemia via Nitric Oxide Release (2003) (14)
A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD): Biomarker study (2016) (14)
Letter by Tanaka and Node Regarding Article, "Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study". (2021) (14)
Home telemonitoring study for Japanese patients with heart failure (HOMES-HF): protocol for a multicentre randomised controlled trial (2013) (14)
Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, pilot study (EFFORT) (2018) (14)
External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors (2021) (14)
N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study (2017) (14)
A reduction of BMI predicts the risk of rehospitalization and cardiac death in non-obese patients with heart failure. (2019) (14)
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy (2020) (14)
Effect of different light–dark schedules on estrous cycle in mice, and implications for mitigating the adverse impact of night work (2017) (14)
Roles of alpha 1-adrenoceptor activity in the release of nitric oxide during ischemia of the canine heart. (1995) (13)
Increased cardiac levels of nitric oxide in patients with chronic heart failure. (2000) (13)
Incretin therapy and heart failure. (2014) (13)
Brachial‐Ankle Pulse Wave Velocity Versus Its Stiffness Index β‐Transformed Value as Risk Marker for Cardiovascular Disease (2019) (13)
Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus (2022) (13)
Relation of Serum Uric Acid and Cardiovascular Events in Adults Aged 20-49 Years. (2021) (13)
Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial (2020) (12)
Ultrasonographic Detection of Thyroid Nodules in Hemodialysis Patients in Japan (2010) (12)
Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study (2018) (12)
Mechanical stretch and angiotensin II increase interleukin-13 production and interleukin-13 receptor alpha2 expression in rat neonatal cardiomyocytes. (2008) (12)
Canine DNA array as a potential tool for combining physiology and molecular biology. (2003) (12)
Hypercholesterolemia Causes Circadian Dysfunction: A Potential Risk Factor for Cardiovascular Disease (2017) (12)
Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study (2013) (12)
Endoscopic thoracic sympathectomy as a novel strategy for vasospastic angina refractory to medical treatments. (2008) (12)
Vesnarinone inhibits adenosine uptake in endothelial cells, smooth muscle cells and myocytes, and mediates cytoprotection. (1997) (12)
Telmisartan as a metabolic sartan for targeting vascular failure. (2008) (12)
A simple method using ex vivo culture of hair follicle tissue to investigate intrinsic circadian characteristics in humans (2017) (12)
Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment (2009) (12)
A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients. (2016) (12)
Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial (2019) (12)
Reduction in incomplete stent apposition area caused by jailed struts after single stenting at left main bifurcation lesions: micro-CT analysis using a three-dimensional elastic bifurcated coronary artery model (2016) (12)
Protein Tyrosine Kinase Is Not Involved in the Infarct Size–Limiting Effect of Ischemic Preconditioning in Canine Hearts (2000) (12)
Pleiotropic effects of ARB on dyslipidemia. (2011) (12)
GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy (2019) (11)
WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study (2021) (11)
A Case Report of Nephrotic Syndrome Due to Collapsing Focal Segmental Glomerulosclerosis Treated With Low‐density Lipoprotein Apheresis (2008) (11)
Update on Hypertension Research in 2021 (2022) (11)
Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: PROLOGUE study. (2014) (11)
Anemia is an independent risk factor for cardiovascular and renal events in hypertensive outpatients with well-controlled blood pressure: a subgroup analysis of the ATTEMPT-CVD randomized trial (2019) (11)
Alpha 1-adrenoceptor activation increases ecto-5'-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. (1995) (11)
A Novel Predictive Model for In-Hospital Mortality Based on a Combination of Multiple Blood Variables in Patients with ST-Segment-Elevation Myocardial Infarction (2020) (10)
Evidence for deactivation of both ectosolic and cytosolic 5'-nucleotidase by adenosine A1 receptor activation in the rat cardiomyocytes. (1994) (10)
How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition? (2020) (10)
Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study. (2018) (10)
Therapeutic potential of α-glucosidase inhibitors to prevent postprandial endothelial dysfunction. (2014) (10)
Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial (2019) (10)
Safety and efficacy of liraglutide treatment in Japanese type 2 diabetes patients after acute myocardial infarction: A non-randomized interventional pilot trial. (2017) (10)
Rationale and design of a study to evaluate effects of pitavastatin on Japanese patients with chronic heart failure: the pitavastatin heart failure study (PEARL study). (2012) (10)
Loss of Endogenous HMGB2 Promotes Cardiac Dysfunction and Pressure Overload-Induced Heart Failure in Mice. (2019) (10)
A Molecular Clock Regulates Angiopoietin-Like Protein 2 Expression (2013) (10)
Potential role of the pancreatic hormone insulin in resetting human peripheral clocks (2018) (10)
Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial (2019) (9)
Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart. (1997) (9)
Increased arterial stiffness and cardiovascular risk prediction in controlled hypertensive patients with coronary artery disease: post hoc analysis of FMD-J (Flow-mediated Dilation Japan) Study A (2020) (9)
Impaired cardiac response to exercise in post-menopausal women: relationship with peripheral vascular function (2003) (9)
Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes　- A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society. (2020) (9)
Official Announcement of Physiological Diagnostic Criteria for Vascular Failure from the Japanese Society for Vascular Failure (2018) (9)
Semiquantitative assessed proteinuria and risk of heart failure: Analysis of a nationwide epidemiological database. (2021) (9)
Cardioprotective effects of low-dose combination therapy with a statin and an angiotensin receptor blocker in a rat myocardial infarction model. (2012) (8)
Activated polymorphonuclear leukocytes induce constriction of canine coronary artery via Mac-1, but not LFA-1, and ICAM-1. (1996) (8)
Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial (2018) (8)
Prognostic Impact of Serum Albumin for Developing Heart Failure Remotely after Acute Myocardial Infarction (2020) (8)
Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure (2018) (8)
752-4 Transient Intracoronary Infusion of ATP After Reperfuslon Reduces the Extent of No-reflow and Infarct Size in Dogs (1995) (8)
Endothelium-derived hyperpolarizing factor and hypertension (2013) (7)
Endogenous nitric oxide inhibits microthromboembolism in the ischemic heart (1994) (7)
A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts. (2005) (7)
Molecular defects associated with antithrombin deficiency and dilated cardiomyopathy in a Japanese patient. (2008) (7)
Renoprotective Effect of Telmisartan in Patients with Chronic Kidney Disease (2008) (7)
Effect of pemafibrate, a novel selective peroxisome proliferator-activated receptor-alpha modulator (SPPARMα), on urinary protein excretion in IgA nephropathy with hypertriglyceridemia (2020) (7)
Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection (2021) (7)
Hypertension in diabetes care: emerging roles of recent hypoglycemic agents (2021) (7)
Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). (2021) (7)
Prediction of acute coronary syndrome by using multislice computed tomography. -Can we predict the onset of acute coronary syndrome? (Pro)-. (2011) (7)
Coexistence of atypical hemolytic uremic syndrome and crescentic IgA nephropathy treated with eculizumab: a case report (2016) (7)
Postprandial hyperglycemia is a possible contributor to paroxysmal atrial fibrillation: a case report. (2006) (7)
Therapeutic potential of monteplase in acute myocardial infarction as a powerful thrombolytic agent for pretreatment of coronary intervention. (2006) (7)
Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases (2021) (7)
Antihypertensive treatment using an angiotensin receptor blocker and a thiazide diuretic improves patients’ quality of life: The Saga Challenge Antihypertensive Study (S-CATS) (2011) (7)
The addition of human iPS cell-derived neural progenitors changes the contraction of human iPS cell-derived cardiac spheroids. (2018) (7)
Fracture of a sirolimus-eluting stent with migration. (2008) (7)
Mobilization of progenitor cells and assessment of vessel healing after second generation drug-eluting stenting by optical coherence tomography (2018) (7)
Usefulness of the SAGE score to predict elevated values of brachial-ankle pulse wave velocity in Japanese subjects with hypertension (2020) (7)
Molecular analysis of ATP-sensitive K(+) channel subunits expressed in mouse portal vein. (2015) (7)
Long-term benefits of monteplase before coronary angioplasty in acute myocardial infarction. (2005) (7)
Inflammation in pulmonary artery hypertension. (2019) (7)
Adenosine-induced cardiac gene expression of ischemic murine hearts revealed by cDNA array hybridization. (2002) (7)
Vascular failure and recent anti-diabetic drugs (2017) (6)
JSH Statement: Kyoto declaration on hypertension research in Asia (2019) (6)
Telmisartan as a metabolic sartan for targeting vascular failure (2008) (6)
Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors. (2021) (6)
Improvement by 5-amino-4-imidazole carboxamide riboside of the contractile dysfunction that follows brief periods of ischemia through increases in ecto-5-nucleotidase activity and adenosine release in canine hearts. (1999) (6)
Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome. (2016) (6)
Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome (2017) (6)
Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society (2020) (6)
Differential effect of a xanthine oxidase inhibitor on arterial stiffness and carotid atherosclerosis: a subanalysis of the PRIZE study (2022) (6)
Glycemic variability and cardiac remodeling in patients with acute myocardial infarction. (2015) (6)
Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study (2021) (6)
Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study (2021) (6)
Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological Database Fasting Plasma Glucose and Colorectal Cancer. (2021) (6)
Rheumatoid Arthritis and Vascular Failure - Rheumatoid Arthritis Is a Risk Factor for Cardiovascular Disease- (2019) (6)
A detection method for latent circadian rhythm sleep-wake disorder (2020) (6)
N-Terminal Pro-B-Type Natriuretic Peptide Is Not a Significant Predictor of Stroke Incidence After 5 Years　- The Ohasama Study. (2018) (6)
Association Between Blood Pressure Classification Using the 2017 ACC/AHA Blood Pressure Guideline and Retinal Atherosclerosis. (2021) (6)
Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus (2018) (6)
Prevalence of prehypertension and left ventricular hypertrophy (2017) (6)
Identification of four novel mutations in F5 associated with congenital factor V deficiency (2009) (6)
Anti-inflammatory Effects of Simvastatin on Human Oral Cells (2007) (6)
Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report (2017) (6)
Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial (2019) (5)
α-Glucosidase Inhibitors: New Therapeutic Agents for Chronic Heart Failure (2006) (5)
Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents (2021) (5)
Risk Factors for Post-Endoscopic Retrograde Pancreatography Pancreatitis: A Retrospective Chart Review in a Regional Hospital in Japan (2019) (5)
Azelnidipine Inhibits the Differentiation and Activation of THP-1 Macrophages through the L-Type Calcium Channel (2018) (5)
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design (2020) (5)
Recommendations for Maintaining the Cardiovascular Care System Under the Conditions of the COVID-19 Pandemic　- 1st Edition, April 2020. (2020) (5)
Rationale and design of the efficacy of rivaroxaban on renal function in patients with non-valvular atrial fibrillation and chronic kidney disease: The X-NOAC study. (2015) (5)
Spatiotemporal dynamics of SETD5-containing NCoR–HDAC3 complex determines enhancer activation for adipogenesis (2021) (5)
Predictive value of high-molecular weight adiponectin in subjects with a higher risk of the development of metabolic syndrome: from a population based 5-year follow-up data. (2013) (5)
Annual reports on hypertension research 2020 (2021) (5)
[Effects of PPARgamma agonist on dyslipidemia and atherosclerosis]. (2010) (5)
Ebstein anomaly by cardiac magnetic resonance imaging. (2009) (5)
Sympathetic nerve activity and endothelial function (2014) (5)
Intracoronary Administration of Adenosine Triphosphate Increases Coronary Blood Flow and Attenuates the Severity of Myocardial Ischemic Injury in Dogs (1999) (5)
A Novel Prediction Model of Acute Kidney Injury Based on Combined Blood Variables in STEMI (2021) (5)
Cardiovascular and renal protective role of angiotensin blockade in hypertension with advanced CKD: a subgroup analysis of ATTEMPT-CVD randomized trial (2018) (5)
Association Between Blood Pressure Lowering and Quality of Life by Treatment of Azilsartan. (2017) (4)
COA-Cl (2-Cl-C.OXT-A) can promote coronary collateral development following acute myocardial infarction in mice (2019) (4)
Therapeutic potential of tofogliflozin on nephrotic syndrome secondary to diabetic nephropathy. (2017) (4)
Inhibitory effects of the novel antagonist of both GP IIb/IIIa and vitronectin receptors on the formation of coronary thromboemboli caused by an inhibition of adenosine receptors during coronary hypoperfusion in dogs (2002) (4)
Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial (2020) (4)
Impact of Renal Dysfunction on Left Atrial Structural Remodeling and Recurrence After Catheter Ablation for Atrial Fibrillation　- A Propensity Score Matching Analysis. (2020) (4)
Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases (2021) (4)
Blood Pressure Classification Using the 2017 ACC/AHA Guideline and Heart Failure in Patients With Cancer (2022) (4)
Effect of a Low-Intensity Pulsed Ultrasound Device, SX-1001, on Clinical Symptoms in Buerger Disease With Limb Ischemia. (2015) (4)
Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological Database. (2021) (4)
Change in Cardiovascular Health Metrics and Risk for Proteinuria Development: Analysis of a Nationwide Population-Based Database (2022) (4)
Effect of Lubiprostone on Urinary Protein Excretion: A Report of Two IgA Nephropathy Patients with Chronic Constipation (2019) (4)
Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake (2015) (4)
The non‐biphenyl‐tetrazole angiotensin AT1 receptor antagonist eprosartan is a unique and robust inverse agonist of the active state of the AT1 receptor (2018) (4)
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus (2020) (4)
Healthcare resource utilization in patients treated with empagliflozin in East Asia (2021) (4)
Promising roles of sodium–glucose cotransporter 2 inhibitors in heart failure prevention and treatment (2020) (4)
Atrial Structural Remodeling in Patients With Atrial Fibrillation Is a Diffuse Fibrotic Process: Evidence From High‐Density Voltage Mapping and Atrial Biopsy (2022) (4)
PCI using a 4‐Fr “child” guide catheter in a “mother” guide catheter: Kyushu KIWAMI® ST registry (2010) (4)
Decline incidence in upper gastrointestinal bleeding in several recent years: data of the Japan claims database of 13 million accumulated patients (2020) (4)
Association between silent ST segment depression in exercise electrocardiography and insulin resistance in obese subjects. (2007) (4)
Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives (2022) (4)
Joint Declaration on COVID-19 by the Japan Stroke and Japanese Circulation Societies (2020) (4)
Nuclear Receptor-mediated Cell-autonomous Oscillatory Expression of the Circadian Transcription Factor, Neuronal PAS Domain Protein 2 (NPAS2)* (2013) (4)
Lifestyle- and Comorbidity-Related Risk Factors Associated with Prescription of Gastric Acid Secretion Inhibitors to Japanese Patients Who Were Helicobacter pylori Negative and Had No Upper Gastrointestinal Lesions (2020) (4)
New Strategy to Prevent Acute Myocardial Infarction by Public Education　- A Position Statement of the Committee on Public Education About Emergency Medical Care of the Japanese Circulation Society. (2021) (4)
Reduction in hsCRP levels is associated with decreased incidence of cardiovascular events in Japanese hypertensive women but not in men (2020) (3)
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan (2022) (3)
The Emerging and Promising Role of Care for Cardiometabolic Syndrome in Prostate Cancer (2019) (3)
Prognostic impact of follow‐up serum albumin after acute myocardial infarction (2021) (3)
Differential effect of concomitant antidiabetic agents on carotid atherosclerosis: a subgroup analysis of the PROLOGUE study (2018) (3)
The effect of continuous positive airway pressure (CPAP) treatment on serum levels of proBDNF and mature BDNF in patients with obstructive sleep apnea (2018) (3)
Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial (2021) (3)
Effects of bezafibrate and simvastatin on plasma lipoproteins in hypercholesterolemia resistant to hormone replacement therapy. (2001) (3)
Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials (2019) (3)
Influence of preoperative serum creatinine level and intraoperative volume of contrast medium on the risk of acute kidney injury after transfemoral transcatheter aortic valve implantation: a retrospective observational study (2019) (3)
Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarction. (2021) (3)
Therapeutic Potential of Monteplase in Acute Myocardial Infarction (2005) (3)
Incidence of aspiration pneumonia during hospitalization in Japanese hospitalized cases did not increase whereas concern factors were exacerbated in a time-dependent manner: analysis of Diagnosis Procedure Combination (DPC) data (2018) (3)
N-Terminal Pro-B-Type Natriuretic Peptide Is a Predictor of Chronic Kidney Disease in an Asian General Population　― The Ohasama Study ― (2019) (3)
[Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis]. (2003) (3)
A novel cardioprotective mechanism of exogenous nitric oxide: inhibition of Rho-associated kinase activity (2015) (3)
Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic　― A Nationwide Survey in Japan by the Japanese Circulation Society― (2021) (3)
Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors　― Insights From a Nationwide Japanese Cohort Study ― (2021) (3)
Nearly Half of Uncontrolled Hypertensive Patients could be Controlled by High-dose Titration of Amlodipine in the Clinical Setting: The ACHIEVE Study (2011) (3)
Asymmetrical Dimethyl Arginine (ADMA) is a Novel Marker of Coronary Stent Restenosis (2002) (3)
Acute Mitral Regurgitation of Unknown Etiology Associated with Disseminated Intravascular Coagulation Eventually Diagnosed as Enterococcus Faecalis Infective Endocarditis by Mitral Valve Surgery (2018) (3)
Remnant-like lipoprotein particle level and insulin resistance are associated with in-stent restenosis in patients with stable angina (2007) (3)
, Toshihiko Preconditioning of the Canine Heart Role of Phasic Dynamism of p 38 Mitogen-Activated Protein Kinase Activation in Ischemic (2001) (3)
Relation of the Metabolic Syndrome to Incident Colorectal Cancer in Young Adults Aged 20 to 49 Years. (2021) (3)
Empagliflozin improves cardiac mitochondrial function and survival through energy regulation in a murine model of heart failure. (2022) (3)
Polymyxin B-immobilized fibre haemoperfusion reduces urinary 8-hydroxy-2?-deoxyguanosine levels in patients with septic shock (2006) (3)
GLUCAGON-LIKE PEPTIDE 1 ANALOG LIRAGLUTIDE REDUCES TNF-α-INDUCED OXIDATIVE STRESS AND INFLAMMATION (2012) (3)
Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure. (2017) (3)
Validity and Reliability of Three-chamber-View Three-directional Encoded Phase-contrast Magnetic Resonance Velocity-Vector Mapping for Transmitral Velocity Measurements: Comparison with Doppler Echocardiography and Intra- and Inter-observer Variability (2016) (2)
Ex vivo Culture Assay Using Human Hair Follicles to Study Circadian Characteristics. (2020) (2)
Body fluid regulation via chronic inhibition of sodium–glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial (2022) (2)
Risk markers for coronary plaque progression and destabilization beyond LDL-cholesterol in acute coronary syndrome. (2014) (2)
Age‐Dependent Relationship of Hypertension Subtypes With Incident Heart Failure (2022) (2)
Abstract of Poster Presentation (2005) (2)
Prediction of Stroke After Cardiac Catheterization: No Reason, No Stroke (2017) (2)
Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy. (2006) (2)
Age Modified Relationship Between Modifiable Risk Factors and the Risk of Atrial Fibrillation. (2021) (2)
Vascular functional tests and preemptive medicine (2020) (2)
Strategy for estimating optimal heart rate in refractory heart failure with relative sinus bradycardia: A case report. (2020) (2)
Impact of Glucose Tolerance and Its Change on Incident Proteinuria: Analysis of a Nationwide Population-Based Dataset (2022) (2)
Impact of low‐density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy (2016) (2)
Fluid volume regulation in patients with heart failure. (2021) (2)
Untreated Hypertension and Subsequent Incidence of Colorectal Cancer: Analysis of a Nationwide Epidemiological Database (2021) (2)
A Method for Culturing Mouse Whisker Follicles to Study Circadian Rhythms ex vivo. (2019) (2)
744-1 Endogenous Nitric Oxide Attenuates Myocardial Inotropic Responses in Ischemic Myocardium of the Canine Heart (1995) (2)
Association Between Waist-to-Height Ratio and Endothelial Dysfunction in Patients With Morbidity　- A Report From the FMD-J Study. (2017) (2)
Simple Risk-Score Model for In-Hospital Major Bleeding Based on Multiple Blood Variables in Patients with Acute Myocardial Infarction (2021) (2)
Serum Albumin and Bleeding Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (from the HAGAKURE-ACS Registry). (2021) (2)
[Prevention of CVD in patients with CKD]. (2008) (2)
A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction (2022) (2)
Long-Term Effect of Febuxostat on Endothelial Function in Patients With Asymptomatic Hyperuricemia: A Sub-Analysis of the PRIZE Study (2022) (2)
[Anti-atherosclerotic effect of fibrates and eicosapentaenoic acid]. (2011) (2)
ACE inhibitors and angiotensin II receptor antagonists independently but synergistically increase coronary blood flow and attenuates the severity of contractile and metabolic dysfunction in ischemic hearts (2002) (2)
Potential Role of Twitter at an Annual Congress in Japan　― Narrative Literature Review of “Tweet the Meeting” ― (2019) (2)
Is GRK2 a new target for cardiovascular disease? (2018) (2)
Does cilnidipine, a dual L- and N-type Ca2+ blocker, shows promise in drug repositioning approaches? (2020) (2)
Oestrogen increases myocardial blood flow in men: assessment by 13N-ammonia positron emission tomography (2004) (2)
Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists (2022) (2)
Multiple potency of ezetimibe in a patient with macroproteinuric chronic kidney disease and statin-intolerant dyslipidemia. (2018) (2)
Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population. (2022) (2)
Role of Adenosine in Cardioprotection (2000) (2)
Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care (2020) (2)
Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy (2020) (2)
Successful treatment of primary cardiac lymphoma causing ST-elevation myocardial infarction by percutaneous coronary intervention combined with chemotherapy (2014) (2)
Microvascular and macrovascular endothelial function in two different types of primary aldosteronism (2018) (2)
Antihypertensive drugs and cancer risk. (2022) (2)
Pleiotropic effects of HMG-CoA reductase inhibitors on cells of the vascular wall (2002) (2)
New-Onset Atrial Fibrillation in Patients With Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease　- Insights From the CLAVIS-COVID Registry. (2022) (2)
Outcomes of Drug-Eluting Stent Thrombosis After Treatment for Acute Versus Chronic Coronary Syndrome. (2021) (2)
IS174 Inhibition of Cardiomyocyte Hypertrophy by Estrogen (2000) (2)
JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension–the JSH Asahikawa declaration (2019) (2)
[Vascular endothelial dysfunction as a mechanistic factor for metabolic syndrome]. (2011) (2)
Natriuretic Peptide–Based Risk Prediction and Assessment of Treatment Effect (2021) (2)
Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry study (2022) (2)
Association between serum urate level and carotid atherosclerosis: an insight from a post hoc analysis of the PRIZE randomised clinical trial (2022) (2)
[Cardio-protective effects of nitric oxide]. (2004) (1)
Novel insights into renovascular hypertension and cardio-renal protection by iron restriction (2016) (1)
Two-Year Experience in “Tweeting the Meeting” During the Scientific Sessions　― Rapid Report From the Japanese Circulation Society ― (2020) (1)
Who Will Be Rehospitalized Next?: Targeting Heart Failure Patients With Brittle Dimensions. (2017) (1)
Glycemic status and the association of change in blood pressure with incident cardiovascular disease. (2022) (1)
Call for Fine Remote Monitoring of Prognostic Signs and Symptoms in Heart Failure. (2021) (1)
Alpha-glucosidase inhibitors: new therapeutic agents for chronic heart failure. (2006) (1)
ENDOTHELIN-1 IS A KEY CANDIDATE TO EXERT PATHOPHYSIOLOGICAL EFFECTS ON CARDIOMYOCYTES DERIVED FROM HYPERTROPHIC CARDIOMYOPATHY-INDUCED PLURIPOTENT STEM CELL (2013) (1)
Construction of a Heart Failure Database Collating Administrative Claims Data and Electronic Medical Record Data to Evaluate Risk Factors for In-Hospital Death and Prolonged Hospitalization (2019) (1)
Suspected Borderline Aldosteronism in Hypertension: The Next Target? (2020) (1)
Development of a Laboratory Risk-Score Model to Predict One-Year Mortality in Acute Myocardial Infarction Survivors (2022) (1)
Spontaneous Internal Mammary Artery Graft Dissection Triggered by Emotional Stress (2019) (1)
A qualitative and quantitative assessment of cardiac cine Phase contrast MRI: comparison of image quality between 2D and 3D acquisition (2015) (1)
1005-77 Is Activation of 5′–-Nucleotidase and Following Adenosine Release a Common Pathway for Mediating Ischemic Preconditioning Among Species? (1995) (1)
Aldosterone Promotes Phosphorylation and Dissociation from Caveolin-1 of eNOS in Endothelial Cells(Endothelium/NO 4 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (1)
Incorporation of Retinal Arteriolosclerosis into Risk Stratification of Blood Pressure Category According to the 2017 ACC/AHA Blood Pressure Guideline (2021) (1)
Full-metal jacket technique using second-generation drug-eluting stent: clinical and angiographic follow-up in 2 years (2019) (1)
979-36 Role of Endogenous Adenosine in Coronary Pressure-Flow Relationship In Dogs (1995) (1)
Role of Activation of Ecto-5’-Nucleotidase for Cardioprotection in Ischemic Preconditioning (1995) (1)
Downward shift of coronary pressure-flow relationship following a brief period of ischemia in dogs (1995) (1)
High-sensitivity assay of plasma cardiac troponin T predicts the effects of pitavastatin in patients with chronic heart failure: a sub-group analysis from the pitavastatin heart failure study (PEARL) (2013) (1)
[An increase in adenosine release contributes to the infarct size limiting effect of ischemic preconditioning]. (1993) (1)
[Vascular endothelial dysfunction]. (2009) (1)
Amlodipine Increases Coronary Blood Flow and Reduces the Severity of Myocardial Ischemia in Canine Hearts : The Role of NO and Adenosine (2002) (1)
Influence of Maintenance of Face-Down Positioning on Physiological and Psychological Factors (2019) (1)
Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19)　― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ― (2021) (1)
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors (2021) (1)
Publisher Correction: Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubes (2019) (1)
Potential negative effect of total parenteral nutrition on the human circadian clock (2022) (1)
Docosahexaenoic Acid with a statin and endothelial function in patients with coronary artery disease. (2015) (1)
[The role of clock genes involved with a hypertension development]. (2014) (1)
Pleiotropic effects of calcium channel blockers (2018) (1)
[Prevention of ischemic heart disease with hyperlipidemia]. (2002) (1)
Association of Life's Simple 7 with incident cardiovascular disease in 52,956 patients with cancer. (2022) (1)
An Appropriate Indication for the Initiation of Beta-Blocker Therapy in Dilated Cardiomyopathy (2005) (1)
Proximal Optimization Technique Facilitates Wire Entry Into Stumpless Chronic Total Occlusion of Side Branch. (2021) (1)
Role of ecto-5′-nucleotidase activation in the infarct-size limiting effect mediated by the opening K+ channels in the canine hearts (1994) (1)
Home Telemonitoring for Japanese Patients with Chronic Heart Failure (2013) (1)
JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction. (2023) (1)
The effects and safety of vildagliptin on cardiac function after acute myocardial infarction. (2015) (1)
PS2-053. Interleukin 27 ameliorates atherosclerosis by inhibiting bone marrow-derived macrophage activation in arterial walls in mice (2011) (1)
Better vascular function tests in cardiovascular care: learning from evidence and providing improved diagnostics to the patient (2021) (1)
Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial (2022) (1)
Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial (2022) (1)
When and for Whom Should We Use SGLT2 Inhibitors in HFrEF? (2020) (1)
[Therapy of metabolic syndrome]. (2006) (1)
Loss of Endogenous HMGB 2 Promotes Cardiac Dysfunction and Pressure Overload-Induced Heart Failure in Mice (2019) (1)
In-stent restenosis following third-generation sirolimus-eluting stent implantation: first report analysed from imaging modalities and histopathological findings. (2020) (1)
EFFECTS OF RIVAROXABAN ON URINARY ALBUMIN EXCRETION IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE: A RANDOMIZED TRIAL (X-NOAC) (2020) (1)
Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors (2022) (1)
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin (2021) (1)
PE-300 High Molecular Weight Adiponectin as a Predictor of Long-Term Clinical Outcome in Patients with Coronary Artery Disease(Atherosclerosis, clinical-07, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (1)
Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction (2022) (1)
Progressive idiopathic nodular glomerulosclerosis mimicking diabetic nephropathy without abnormal glycemic metabolism (2016) (1)
Abstract 9549: Effects of Canagliflozin in Patients With Type 2 Diabetes and Chronic Heart Failure: A Randomized Clinical Trial (CANDLE) (2019) (1)
[Behçet disease with exacerbation in summer and late coronary stent occlusion]. (2004) (1)
Effect of rivaroxaban on urinary albumin excretion in patients with atrial fibrillation and chronic kidney disease: a randomized trial (X-NOAC) (2020) (1)
Sex Difference in the Association between Lipid Profile and Incident Cardiovascular Disease among Young Adults (2022) (1)
Comparing the Effects of Canagliflozin vs. Glimepiride by Body Mass Index in Patients with Type 2 Diabetes and Chronic Heart Failure: A Subanalysis of the CANDLE Trial (2022) (1)
KATP channel opener mimics ischemic preconditioning (2006) (1)
PS 13-05 PENTRAXIN-3 REGULATES THE INFLAMMATORY ACTIVITY OF MACROPHAGES (2016) (1)
Nationwide Survey of Japanese Cardiac Rehabilitation Training Facilities During the Coronavirus Disease 2019 Outbreak (2021) (1)
OE-009 The Possible Role of Oxidative Stress Caused by Uncoupled eNOS in Left Ventricular Remodeling after Myocardial Infarction in Rats(Chronic coronary heart disease/Remodeling-1 (IHD) OE2,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Societ (2006) (1)
Cardiac acoustic biomarkers as surrogate markers to diagnose the phenotypes of pulmonary hypertension: an exploratory study (2021) (1)
Reduction in blood pressure for elevated blood pressure/stage 1 hypertension according to the ACC/AHA guideline and cardiovascular outcomes. (2022) (1)
66 Fabrication of Engineered Pulsatile 3-Dimensional Scaffold-Free Cardiac Tissue from Embryonic Stem Cells (2011) (1)
PS-BPC05-8: RELATIONSHIP BETWEEN EXECUTIVE DYSFUNCTION AND READMISSION IN PATIENTS WITH HEART FAILURE (2023) (0)
SUN-224 N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IS A PREDICTOR OF CHRONIC KIDNEY DISEASE INCIDENCE IN AN ASIAN GENERAL POPULATION:THE OHASAMA STUDY (2019) (0)
Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions (update) (2022) (0)
[Cardioprotective effect of estrogen]. (2005) (0)
PE-425 BNP Promotes Angiogenesis by VEGF Production Via JAK2/STAT3 and ERK Signaling Pathway in Human Endothelial Cells(Endothelium-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Effect of Novel Stratified Lipid Risk by "LDL-Window" and Flow-Mediated Dilation on the Prognosis of Coronary Artery Disease Using the FMD-J Study A Data. (2022) (0)
PS-C04-11: EFFECT OF ANKLE BRACHIAL INDEX EXAMINATION ON CENTRAL AORTIC BLOOD PRESSURE IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (2023) (0)
Differential Effect on Acute Cardioprotection against Myocardial Infarction by Statins : Role of ECTO-5'-Nucleotidase (2003) (0)
Appropriate mineralocorticoid receptor antagonism and salt restriction are essential for primary aldosteronism therapy (2023) (0)
Impact of the glycemic control status on the 2-year progression of the arterial stiffness in add-on a dipeptidyl peptidase 4 inhibitor treatment (2016) (0)
PS-C05-5: CLINICAL IMPACT OF CREDO-KYOTO RISK SCORE ON IN-HOSPITAL BLEEDING IN PATIENTS WITH ACUTE CORONARY SYNDROME (2023) (0)
PS 13-13 EGCG, A GREEN TEA CATECHIN, ATTENUATES THE PROGRESSION OF HEART FAILURE INDUCED BY THE HEART/MUSCLE-SPECIFIC DELETION OF MnSOD IN MICE (2016) (0)
Relationship between Canagliflozin, Sodium Glucose Cotransporter 2 Inhibitor, and Hematopoietic Effects in Patients with Diabetes and Mild Heart Failure: Results from the CANDLE trial. (2023) (0)
Clinical impact of CREDO-kyoto risk score on in-hospital bleeding in patients with acute coronary syndrome (2021) (0)
Effectiveness of therapy with pitavastatin is associated with plasma interleukin-8 levels and improved cardiovascular outcomes in patients with chronic heart failure (2013) (0)
Interleukin-13 as a marker for cardiovascular disease (2006) (0)
A14070 EGCG attenuate cardiac hypertrophy in the hypertensive Dahl rats (2018) (0)
Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE Study (2022) (0)
Effect of add-on empagliflozin on arterial stiffness in patients with type 2 diabetes and cardiovascular disease: an analysis from a placebo-controlled EMBLEM trial (2022) (0)
Prediction of Vulnerable Plaque with Inflammatory Markers in Vulnerable Patients(Approach to Vulnerable Plaque and Vulnerable Patient, The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
5 Management of Vulnable Plaque and Vulnable Patients(ACC-JCS Joint Symposium "Detection and Treatment of Vulnerable Patients", The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
PS-B02-7: THE LONG NON-CODING RNA CAREN IMPROVES CARDIAC DYSFUNCTION IN AGED MICE (2023) (0)
[Coronary plaque and endothelial function]. (2011) (0)
ENDOTHELIN-1 INDUCES CONTRACTION VARIABILITY IN HYPERTROPHIC CARDIOMYOPATHY-INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES (2014) (0)
Mediators of the effects of canagliflozin on N‐terminal pro‐brain natriuretic peptide concentration: An exploratory mediation analysis of the randomized CANDLE trial (2022) (0)
Effect of Coronary Perfusion on Myocardial Contractility in the Heart (1994) (0)
Plasma High-Molecular Weight Adiponectin Levels in Patients with Congestive Heart Failure (2006) (0)
A NOVEL PREDICTION MODEL OF IN-HOSPITAL MAJOR BLEEDING BASED ON MULTIPLE BLOOD VARIABLES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (2023) (0)
939-77 Cellular Mechanisms for Alpha1-adrenoceptormediated Cardioprotection: Role of Protein Kinase C and Ecto-5’-Nucleotidase in Ischemic Preconditioning (1995) (0)
Protective Effects of Erythropoietin in Patients with Chronic Kidney Disease (2011) (0)
Abstract 809: Pentraxin 3 (PTX3) as a Novel Marker for Stent-induced Inflammation and Coronary Restenosis (2006) (0)
Preischemic Protein Kinase-A Activation Triggers Cardioprotection of Ischemic Preconditioning via the Inhibition of Rho-Kinase (2003) (0)
Activation of Ecto-5’-nucleotidase Mediates Cardioprotection in Ischemic Preconditioning: Important Role of Protein Kinase C (1997) (0)
S-24-2: IMPACT OF FEBUXOSTAT ON VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY: INSIGHTS FROM THE RANDOMIZED PRIZE STUDY (2023) (0)
Need for more evidence of safety in the pharmacological therapy of anemia in chronic kidney disease: a cardiovascular perspective. (2022) (0)
Effects of Particulate Matters on Cardiovascular Disease (2017) (0)
Long Pentraxin PTX3 as a Novel Marker for Stent-induced Inflammation and Coronary Restenosis(Additional Remarks, New Evidence of Coronary Artery Disease-Pathogenesis, Diagnosis and Therapy, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Abstract 18666: What are Key Factors to Achieve Better Stent Apposition at Left Main Bifurcation by Culottes Stenting Technique? Micro-CT Analysis Using Bifurcated Elastic Coronary Artery Models (2014) (0)
NT-proBNP in Heart Failure With Preserved Ejection Fraction: Quest for a Marker Reflecting the Truth. (2020) (0)
Takotsubo Syndrome After Additional Right Ventricular Lead Insertion in a Pacemaker User (2022) (0)
PJ-401 Comparison of CABG and PCI with Drug-eluting Stent (DES) for the Treatment of 3-vessel Disease(PJ068,Coronary Revascularization, PCI (DES) 2 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
2. Heart Failure Therapy for Healthy Aging (2020) (0)
In‐hospital therapy for worsening heart failure: black box or sweet spot? (2021) (0)
6-LB: Estimated Fluid Volume Status following Initiation of Empagliflozin in Patients with Type 2 Diabetes and Cardiovascular Disease (2021) (0)
Association of Cardiovascular Health Metrics with Risk of Transition to Hypertension in Non-Hypertensive Young Adults. (2022) (0)
Amelioration of arterial pressure lability: an unmissable target for diabetes management (2017) (0)
An Adenosine Analogue, Chloroadenosine, Attenautes Pressure-Overload Myocardial Hypertrophy in Mice (2002) (0)
PE-458 Simvastatin Induces Vascular Endothelial Growth Factor Production by the Up-regulation of Hypoxia-inducible Factor-1 α in Endothelial Cells(Growth factor/Cytokine-2 (H) PE77,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
Gene Expression Profile of Failing Human Hearts In Patients with Dilated Cardiomyopathy Using "Gene Chip" Analysis (2002) (0)
P3619Incidence of progressively reduced LVEF during long-year follow-up after myocardial infarction: impact for mid-term outcomes (2019) (0)
Medical agents acting on the renin–angiotensin–aldosterone axis for the treatment of heart failure (2010) (0)
Relationship between Cardiac Acoustic Biomarkers and Pulmonary Artery Pressure in Patients with Heart Failure (2022) (0)
Abstract 4848: Angintensin II Stimulates Microtubule Reorganization Mediated by SIRT2 in Endothelial Cells (2009) (0)
Do antilipidemic agents reduce blood pressure (2018) (0)
De-Escalation Therapy After PCI in ACS Patients With Chronic Kidney Disease (2023) (0)
Linagliptin exacerbates heart failure due to energy deficiency via downregulation of glucose utilization and absorption in a mouse model. (2023) (0)
Advance care planning from the penultimate hospitalization in patients with end-stage heart failure: a single-center, 10-year experience (2021) (0)
Correction to: Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions (update) (2022) (0)
PE-139 Asleep Ultra Low Frequency Power (ULF) and Very Low Frequency Power (VLF) Predict the Severity of SAS in the Cardiovascular Patients(Autonomic nervous system-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
[Methods to evaluate the vascular endothelial function]. (2006) (0)
Role of Tissue Factor in Vascular Failure. (2018) (0)
AW-AD-4: RENOPROTECTIVE EFFECTS OF CANAGLIFLOZIN VIA LESSENING HYPERINSULINEMIA IN DIABETIC PATIENTS WITH HEART FAILURE: A POST-HOC ANALYSIS OF THE CANDLE TRIAL (2023) (0)
Efficacy of Cardiac Computed Tomography for Obstructive Mechanical Valve Thrombosis Under Venoarterial Extracorporeal Membrane Oxygenation (2022) (0)
Endothelium-Derived Hyperpolarizing Factor Ameliorates Ischemic Heart Failure (2001) (0)
Pleiotropic Effects of Statin in Cardiovascular Protection (2009) (0)
[Effects of incretin on cardiovascular disease and risk factors]. (2011) (0)
ilostazol Inhibits Leukocyte Integrin ac-1 , Leading to a Potential Reduction n Restenosis After Coronary Stent Implantation (2016) (0)
Effect of Anagliptin versus Sitagliptin on Renal Function: Subanalyzes from the REASON Trial (2022) (0)
Effect of canagliflozin on white blood cell counts in patients with type 2 diabetes and heart failure: A subanalysis of the randomized CANDLE trial (2022) (0)
Effect of Eicosapentaic Acid and HMG-CoA Reductase Inhibitor on Chronic Heart Failure (2012) (0)
A case of Fabry's disease initially diagnosed after the initiation of hemodialysis, which was successfully controlled by enzyme replacement therapy (2010) (0)
Crosstalk between the liver and heart: revisited for prevention and treatment (2020) (0)
P6440Mid-term outcomes of second-generation drug-eluting-stent implantation for left main coronary artery disease compare with first-generation drug-eluting-stent (2018) (0)
448-P: Secondary Analyses to Assess the Profound Effect of Empagliflozin on Endothelial Function in Patients with Type 2 Diabetes and Established Cardiovascular Diseases: The Placebo-Controlled Double-Blind Randomized EMBLEM Trial (2020) (0)
Glimepiride: an old antidiabetic medication with potential as a new cardiovascular therapeutic? (2023) (0)
Sex Differences in Clinical Outcomes Among Patients With COVID-19 and Cardiovascular Disease　― Insights From the CLAVIS-COVID Registry ― (2022) (0)
Abstract 14105: Apoptosis Inhibitor of Macrophage Activates Inflammatory Response After Acute Myocardial Infarction (2015) (0)
Second Nationwide Survey of Japanese Cardiac Rehabilitation Training Facilities During the Coronavirus Disease 2019 (COVID-19) Outbreak (2022) (0)
3 Value of Biomarker in Acute Coronary Syndrome(Can we predict the onset of acute coronary syndrome?,Controversy (C-1) (I),Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
S-20-2: IS HYPERTENSION A CAUSE OF ATRIAL CARDIOMYOPATHY IN PATIENTS WITH ATRIAL FIBRILLATION? -EVIDENCE FROM ATRIAL BIOPSY- (2023) (0)
Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial (2022) (0)
Abstract 10899: Matrix Metalloproteinase-9 Might Contribute to Mobilization of Bone Marrow-Derived Cells After Coronary Stent Implantation (2011) (0)
4. Primary Prevention of Hypertension (2007) (0)
Preischemic Protein Kinase-A Activation Evokes Ischemic Preconditioning through Rho-Kinase Inhibition Independent of Protein Kinase-C : A Novel Mechanism (2003) (0)
PS 14-04 THE EFFECTS OF THE VILDAGLIPTIN FOR CARDIAC DYSFUNCTION AFTER THE ACUTE MYOCARDIAL INFARCTION (2016) (0)
Erratum to: Design and Rationale of Japanese Evaluation Between Formula of Azelnidipine and Amlodipine Add on Olmesartan to Get Antialbuminuric Effect Study (J-FLAG) (2011) (0)
Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes (2020) (0)
Sulfaphenazole, an Inhibitor of Cytochrome 2C9, Ameliorates Impaired NO-mediated Coronary Arteriolar Vasodilation in Spontaneously Hypertensive Rats-Direct In Vivo Visualization(Coronary Circulation, Basic/Clinical 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Atherosclerosis (WS-022) Chairpersons: Toru Miyazaki, Andrew Lichtman (2010) (0)
Low HbA1c Level and High Mortality: A Reversal of Cause and Effect? (2021) (0)
[Aging of cardiovascular system and female hormone--heart failure and estrogen]. (2003) (0)
PS1-29 Interleukin 27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice (2010) (0)
First report of lotus root-like appearance at the site of coronary spasm in a patient with acute coronary syndrome. (2020) (0)
Effect of febuxostat on the level of malondialdehyde-modified low-density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study. (2023) (0)
N-Terminal Pro-B-Type Natriuretic Peptide Is a Predictor of Chronic Kidney Disease in an Asian General Population (2019) (0)
AZELNIDIPINE INHIBITS MACROPHAGE ACTIVATION BY REDUCING THE EXPRESSION OF LOX–1 AND THE UPTAKE OF ACETYLATED LDL IN THP–1 CELLS (2013) (0)
II. Prevention of Cardiac-events by Treatments of Lifestyle Diseases (2019) (0)
Asynchronous Rhythm of Steroidogenic Factor 1 and Period Homolog 2 mRNA Expression in Mouse Y1 Adrenocorticol Tumor Cells (2010) (0)
New Vision, Mission, and Values of the Japanese Circulation Society. (2021) (0)
PS-C17-4: ASSOCIATION BETWEEN SERUM INSULIN LEVELS AND HEART FAILURE-RELATED PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE (2023) (0)
Effect of Canagliflozin on Estimated Fluid Volumes in Patients with Heart Failure and type 2 Diabetes: A Post-hoc Analysis of the CANDLE Trial (2021) (0)
GLP-1 ANALOG LIRAGLUTIDE INDUCED CARDIAC DYSFUNCTION DUE TO ENERGETIC STARVATION IN HEART FAILURE WITH NON-DIABETIC DILATED CARDIOMYOPATHY IN HAMSTERS (2021) (0)
Interatrial conduction time is associated with left atrial low voltage area and predicts the recurrence after single atrial fibrillation ablation (2023) (0)
Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction. (2022) (0)
Lipid Disorder and Heart Failure (2007) (0)
Relationship of normal-weight central obesity with the risk for heart failure and atrial fibrillation: analysis of a nationwide health check-up and claims database (2022) (0)
Abstract 1546: High-Molecular Adiponectin as a Marker of Coronary Artery Disease (2007) (0)
Benefits and risks of combination therapy in hypertension (2009) (0)
Effect of incretin-related drugs to cardiovascular events in patients with type 2 diabetes mellitus (2013) (0)
Synergic role of opening of the sarcolemmal and mitochondrial ATP-sensitive K+ channels in ischemic preconditioning (2000) (0)
Abstract 12801: Epigallocatechin Gallate Attenuates the Progression of Heart Failure Induced by Heart/muscle-specific Deletion Of Mn-SOD in Mice Through Scavenging Free Radicals and Improving the Cardiac Chronic Inflammation (2012) (0)
[ADMA (asymmetric dimethyl arginine) and coronary artery disease]. (2003) (0)
HYPERINTENSE CORONARY PLAQUE ON NON-CONTRAST T1-WEIGHTED CARDIAC MAGNETIC RESONANCE IS ASSOCIATED WITH CAROTID ARTERY INFLAMMATION EVALUATED BY [18F]-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (2010) (0)
The ATP-sensitive Potassium Channel Opener, Nicorandil, Reduces No-reflow Phenomenon and Infarct Size in the Canine Heart (2002) (0)
[Coronary circulation and cardiac function]. (2003) (0)
1 CKD and Ischemic Heart Disease(The Mechanism and Management of Cardio-renal Risk,Roundtable Discussion 3 (RT-3) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
PJ-791 Angiotensin II and a CXC Chemokine, IP10, Constitute a Positive Feedback Loop that Stimulates Local Renin-angiotensin System in Endothelial Cells(Growth factor/Cytokine-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Hair greying in castrated mice (2022) (0)
Author Correction: A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction (2022) (0)
Xanthine oxidase inhibition for cardiovascular disease prevention (2022) (0)
Influence of left ventricular ejection fraction on the reduction in N-terminal pro-brain natriuretic peptide by canagliflozin in patients with heart failure and type 2 diabetes: A sub analysis of the CANDLE trial. (2022) (0)
AP19-01069 Abstract View (2019) (0)
The effect of switching from statin-monotherapy to statin/ezetimibe combination therapy on lipid profiles in patients with type 2 diabetes and dyslipidemia: a multicenter open-label study (EUCLID) (2020) (0)
A Cost-benefit Analysis of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting using Reimbursement Data of Japan: A Single-center Pilot Study (2018) (0)
PS-C04-6: ASSOCIATION BETWEEN SERUM URATE LEVEL AND CAROTID ATHEROSCLEROSIS: AN INSIGHT FROM A POST-HOC ANALYSIS OF THE RANDOMIZED CLINICAL TRIAL (PRIZE) (2023) (0)
Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial (2020) (0)
[Basic efficiently of drug eluting stent 2011]. (2011) (0)
CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY IMPROVES ENDOTHELIAL FUNCTION AND NEUTROPHIL-LYMPHOCYTE RATIO IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME (2015) (0)
Increased Plasma IL-13 Levels in Chronic Heart Failure that Promotes B-type Natriuretic Peptide Production from Vascular Endothelial Cells (Heart Failure, Basic 6 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Abstract 1042: BNP Promotes Angiogenesis by VEGF Production via JAK2/STAT3 and ERK Signaling Pathway in Human Endothelial Cells (2006) (0)
What More Can Be Delivered to Future Patients with Coronary Syndromes? (2022) (0)
Nisoldipine Selectively Induces Coronary Vasodilation and Improves Mild Myocardial Ischemia in Dogs: A Potential Role of Cellular Acidosis (1998) (0)
Obesity Is a Culprit in Heart Failure: Do NOT Miss HFpEF, Especially in Obese Women. (2018) (0)
4 What should we do for the women medical students and junior residents?(Symposium 20 (SY-20) (H) The State and the Future for Women in Cardiology,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
Difference in the Influence of the Lipid Profile as a Coronary Risk Factor in Patients with and Without Diabetes Mellitus (2005) (0)
[Therapy for metabolic syndrome]. (2006) (0)
The Long-acting Calcium Channel Blockers Attenuate Cardiac Hypertrophy Induced by Chronic NO Inhibition : The Investigation of the Potential Subcellular Mechanisms (2002) (0)
Adenosine therapy: A new approach to ischemic heart disease (2001) (0)
PS-C34-7: EFFECT OF FEBUXOSTAT ON THE LEVEL OF MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEIN, AS AN OXIDANT MARKER, FROM THE SUB-ANALYSES OF PRIZE STUDY (2023) (0)
Different types of Kounis syndrome caused by different episodes of bee sting anaphylaxis: Misfortunes never come singly. (2022) (0)
A Selective Estrogen Receptor Modulator, Raloxifene, Inhibits the Cardiac Hypertrophy and Dysfunction due to Aortic Banding in Mice (2003) (0)
III. Treatment of Heart Failure; 3. Novel Topics of Pharmacological Therapy for Chronic Heart Failure (2020) (0)
So‐far overlooked HFpEF patients with normal natriuretic peptide level need more evidence (2022) (0)
Multimodality Imaging Approach for a Left Ventricular Aneurysm in a Patient With Myocardial Infarction and Non-Obstructive Coronary Arteries. (2022) (0)
Effects of pitavastatin on Japanese patients with chronic heart failure: a subanalysis of the PEARL (2013) (0)
Role of Activation of Ecto-5’-Nucleotidase for Cardioprotection in Ischemic and Reperfusion Injury: Role of Purine and Adenosine Metabolism (1996) (0)
Medication Naïve Blood Pressure and Incident Cancers: Analysis of Two Nationwide Population-Based Databases. (2022) (0)
Prognostic impact of initial serum albumin for newly developing heart failure after acute myocardial infarction (2020) (0)
Management of anticoagulant therapy using a portable point-of-care international normalized ratio device and social networking service in a patient with a left ventricular assist device. (2020) (0)
Impact of Tweeting Summaries by the Japanese Circulation Society Official Account on Article Viewership　- Pilot Trial. (2022) (0)
Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial (2022) (0)
Abstract 4846: Rab5a-mediated Localization at Cell-cell Contacts of a Tight Junction Protein Claudin-1 is Regulated by Proteasome in Endothelial Cells (2009) (0)
JS-HR-8: PROGRESS OF OBESITY/DIABETES IN AREA OF HYPERTENSION RESEARCH 2021 (2023) (0)
A NOVEL PREDICTIVE MODEL FOR IN-HOSPITAL MORTALITY BASED ON BLOOD EXAMINATION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (2020) (0)
Age-Specific Relation of Cardiovascular Health Metrics With Incident Cardiovascular Disease. (2022) (0)
P894Losing body weight is a strong independent predictor of rehospitalization and prognosis in patients with heart failure (2018) (0)
Abstract P162: Comparison Of The Clinical Effect Of Empagliflozin On Glycemic And Non-glycemic Parameters In Japanese Patients With Type 2 Diabetes And Cardiovascular Disease Treated With Or Without Baseline Metformin (2021) (0)
大動脈バンディングの結果、マウスにおいて心肥大と心機能不全を阻害する選択的エストロジェン受容体モジュレータ・ラロキシフェン (2003) (0)
P5383The coronary collateral development by angiogenesis of COA-Cl (2-Cl-C.OXT-A) in myocardial infarction (2017) (0)
Angiotensin II Stimulates Endothelial Cell Migration via SIRT2-mediated Deacetylaion of α-tubulin (2008) (0)
[The trend of research on the mechanism of reperfusion injury]. (2003) (0)
Abstract 12206: Mobilization of Bone Marrow-Derived Endothelial Progenitor Cells and Re-Endothelialization After Coronary Stent Implantation -Assessment in Second Generation Drug Eluting Stents- (2013) (0)
Asynchronous Rhythm of Ad4BP/SF-1 and Per2 Expression in Adrenal Tumors of Cushing’s Syndrome (2018) (0)
The role of albumin level in cardiovascular disease: a review of recent research advances (2022) (0)
PS 13-17 APOPTOSIS INHIBITOR OF MACROPHAGE ACTIVATES INFLAMMATORY RESPONSE AFTER ACUTE MYOCARDIAL INFARCTION (2016) (0)
Association of cardiovascular health metrics with annual incidence of prediabetes or diabetes: Analysis of a nationwide real‐world database (2022) (0)
Letter by Sawami et al Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)". (2023) (0)
Abstract 10951: Serial Change in Tissue Characteristics During Plaque Regression Process by Statins-Virtual Histology Intravascular Ultrasound Evaluation (2011) (0)
Abstract 15339: Assessment of Vessel Healing After Second Generation Drug Eluting Stenting by Optical Coherence Tomography (2017) (0)
The role of cell-autonomous circadian oscillation of Cry transcription in circadian rhythm generation. (2022) (0)
Development of 3-Dimensional Prevascularized Scaffold-Free Contractile Cardiac Patch for Heart Regeneration (2013) (0)
Evolution of Studies on Vascular Endothelial Function (2017) (0)
[A 71-year-old man with chest pain]. (2005) (0)
How to Measure DELIVERed Benefits of Dapagliflozin in the Management of HFmrEF/HFpEF? (2023) (0)
Prediabetes in Young Adults and Its Association with Cardiovascular Health Metrics in the Progression to Diabetes. (2022) (0)
[Characteristics of elderly patients with ischemic heart disease]. (2011) (0)
A new development of high fidelity canine DNA microarray: application for the assessment of gene expressions of reversibly or irreversibly injured ischemic myocardium (2002) (0)
Is It Time to Shift the Monotherapy After Percutaneous Coronary Intervention From Aspirin to P2Y12Inhibitors?　- New Normal in the New-Generation Era. (2021) (0)
Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: Practical Application. (2023) (0)
Multiple Cardiovascular Diseases or Risk Factors Increase the Severity of Coronavirus Disease 2019. (2021) (0)
Abstract 18138: Molecular Mechanism Whereby Activated State of the Angiotensin II Type 1 Receptor Attenuate Inverse Agonist Efficacy (2011) (0)
P3604Gender difference in Low-BMI patients with acute myocardial infarction makes an impact on mid-term outcomes (2019) (0)
COA-Cl (2-Cl-C.OXT-A) can promote coronary collateral development following acute myocardial infarction in mice (2019) (0)
Beneficial Role of Interaction Between Alpha-Adrenoceptor Activity and Adenosine in Myocardial Ischemic and Reperfusion Injury (1994) (0)
PJ-084 Anti-atherosclerotic Actions of an Angiotensin Receptor Blocker, Losartan, in Patients with Essential Hypertension(Hypertension, clinical-11 (H) PJ14,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study (2017) (0)
A NOVEL RISK-SCORE MODEL OF IN-HOSPITAL ACUTE KIDNEY INJURY BASED ON COMBINED BLOOD VARIABLES IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (2021) (0)
Abstract 13889: Endothelin-1 Has a Pivotal Role in Contraction Variability in Hypertrophic Cardiomyopathy-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (2012) (0)
979-31 Intravenous Infusion of ATP Increases Coronary Blood Flow and Improves Ischemia via Elevation of Myocardial Adenosine Levels due to Degradation of ATP (1995) (0)
PS-C24-4: QUANTIFICATION OF EXERCISE-INDUCED HEMODYNAMIC CHANGE BY HEART SOUND ANALYSIS IN PATIENT WITH HEART FAILURE (2023) (0)
Interaction of Blood Pressure and Glycemic Status in Developing Cardiovascular Disease: Analysis of a Nationwide Real‐World Database (2022) (0)
PS 11-73 BLOOD PRESSURE AND BODY WEIGHT LOWERING EFFECTS OF SODIUM-GLUCOSE CO-TRANSPORT 2 (SGLT2) INHIBITORS. (2016) (0)
Effects of Statin Treatment in Japanese Patients with Heart Failure (PEARL Study): Rationale and Study Design (2008) (0)
Reduction in blood pressure for people with isolated diastolic hypertension and cardiovascular outcomes. (2022) (0)
The selective estrogen receptor modulator, raloxifene, improves the severity of myocardial ischemia in canine hearts (2002) (0)
Abstract 15465: Effect of Sitagliptin on Left Ventricular Function in Patients With Type 2 Diabetes a Sub Analysis of the PROLOGUE Study (2016) (0)
Pathogenic connection between hypertension and type 2 diabetes: how do they mutually affect each other? (2022) (0)
PS-C02-5: HYPERTENSION IS NOT A PREDICTOR OF ATRIAL FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION - EVIDENCE FROM ATRIAL BIOPSY (2023) (0)
Hair greying in castrated mice [version 1; peer review: awaiting peer review] (2022) (0)
AHA-Circ. Research (2001) (0)
Tumor necrosis factor-α(TNF) exacerbates myocardial ischemia/reperfusion (I/R) injury, but partially reduces infarct size after permanent myocardial ischemia in mice (2002) (0)
OE-198 Molecular Mechanism of Insurmountable Antagonism of the Angiotensin II Type 1 Receptor by Non-peptide Antagonists(Metabolism/Biochemistry/Energetics-1 (H) OE33,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
Partial Blood Recirculation: A New Trial for Prolonging Filter Life During Continuous Hemodiafiltration (2008) (0)
Pathophysiological Association Between Serum Uric Acid and Vascular Damages in Subjects with Hypertension (2018) (0)
PS-C05-1: INCIDENCE OF VERY REDUCED LEFT VENTRICULAR EJECTION FRACTION DURING LONG-TERM FOLLOW-UP AFTER ACUTE MYOCARDIAL INFARCTION: IMPACT FOR MID-TERM OUTCOMES (2023) (0)
Efficacy of Cardiac Computed Tomography for Diagnostic and Therapeutic Evaluation of Bioprosthetic Valve Thrombosis. (2022) (0)
Abstract 234: Identification of a Novel Cardiomyocyte-enriched Long Noncoding Rna Counteracting Against Heart Failure Development (2020) (0)
Abstract 13507: Dk-Crush Stenting Increases the Risk of Incomplete Stent Apposition Compared With Culotte Stenting for the Treatment of Left Main Coronary Bifurcation Lesion: Analysis From Micro CT (2019) (0)
Takotsubo cardiomyopathy in the presence of right ventricular apical pacing: A case report (2014) (0)
CORRIGENDUM: N-Terminal Pro-B-Type Natriuretic Peptide Is a Predictor of Chronic Kidney Disease in an Asian General Population　― The Ohasama Study ― (2020) (0)
Association between proteinuria and incident colorectal cancer: analysis of a nationwide population-based database (2022) (0)
Abstract 17044: Myeloid-Related Protein 8/14 Implicated in Atherothrombosis According to Activated Leukocyte (2013) (0)
Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial (2019) (0)
Errors Identified by Early, Risk-adapted, Triggered On-site Monitoring in Physician-initiated Clinical Trials not for Regulatory Approval in Cardiovascular Diseases (2023) (0)
Dose-dependent relationship of blood pressure and glycemic status with risk of aortic dissection and aneurysm. (2022) (0)
Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubes (2019) (0)
2. Glucose-metabolic Network and Cardiovascular Failure (2022) (0)
Long-year follow-up of acute myocardial infarction with preserved initial LVEF: prognostic impact of progressively reduced LVEF (2020) (0)
Response to: Telmisartan and Carotid Intima-Media Thickness Regression: A Class Effect of Angiotensin-Receptor Blockers? (2008) (0)
Abstract 9487: Implantation of Scaffold-Free Tubular Tissue Using a Bio-3D Printer Augments Vascular Remodeling and Endothelialization (2014) (0)
Clinical diagnosis of metabolic syndrome 4. Therapy for metabolic syndrome. (2007) (0)
What Is Behind the HbA1c Value? (2021) (0)
An Assessment of the Current Status on the Palliative Care in Patients with End-of-life Stage Heart Failure (2014) (0)
Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19 (2022) (0)
Empagliflozin improves prognosis and energetic properties through modulating mitochondrial function in failing murine hearts (2021) (0)
S-17-6: SGLT2 INHIBITION ON VASCULAR FUNCTION AND ATHEROSCLEROSIS: CLEARED OR YET? (2023) (0)
The New Metalloproteinase Inhibitor Blocks Cardiac Hypertrophy Induced by both Phenylephrine and Angiotensin II (2002) (0)
Canagliflozin independently reduced plasma volume from conventional diuretics in patients with type 2 diabetes and chronic heart failure: a subanalysis of the CANDLE trial (2022) (0)
A Role of Transient Preischemic Activation of Protein Kinase-A in Ischemic Preconditioning in Vivo : Involvement of p38 Mitogen-activated Protein Kinase (2002) (0)
Intra- and interobserver variability of left ventricular diastolic inflow parameters measured by three chamber view 2D cine three-directionally encoded (3Ch. 2D-cine-3 dir.) Phase contrast MR velocity vector map (2013) (0)
Molecular Mechanism of Attenuated Inverse Agonism of ARBs for Active-Stateof AT1 receptor (2015) (0)
Ecto-5′-Nucleotidase and Cardioprotection (1998) (0)
ATORVASTATIN ATTENUATES CARDIOVASCULAR INFLAMMATION AND OXIDATIVE STRESS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (2013) (0)
Pitavastatin in the treatment of hypercholesterolemia: the experience in Japan (2011) (0)
Effects of Low-Dose Colchicine on Serum High-Sensitivity C-Reactive Protein Level in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus and Enhanced Inflammatory Response Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase 2, Dose-Finding Study (2022) (0)
Inhibitory Effects of the CP Compound on Coronary Thromboemboli Caused by an Inhibition of Adenosine Receptors during Coronary Hypoperfusion (2002) (0)
Role of opening of ATP-sensitive K+ channels in cardioprotection afforded by ischemic preconditioning-investigation of cellular mechanisms (1999) (0)
Menopause accelerates early carotid atherosclerosis in non-diabetic subjects (2000) (0)
Clinical roles of vascular function assessment in cancer care (2021) (0)
EFFECTS OF FEBUXOSTAT ON CAROTID INTIMA-MEDIA THICKNESS IN ASYMPTOMATIC HYPERURICEMIA: A RANDOMIZED CLINICAL TRIAL (PRIZE) (2020) (0)
[Concept of vascular failure]. (2007) (0)
VIII. Clinical Features of COVID-19 in the Aspects of Thrombus, Gerontology, and Therapeutics for Hypertension (2020) (0)
Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry (2022) (0)
Design and Rationale of Japanese Evaluation Between Formula of Azelnidipine and Amlodipine Add on Olmesartan to Get Antialbuminuric Effect Study (J-FLAG) (2011) (0)
Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan (2021) (0)
A case of cardiac tamponade due to uremic pericarditis successfully treated with only one-time pericardiocentesis after intensive hemodialysis (2009) (0)
[Diagnostic approach and modalities for coronary artery disease in patients with diabetes mellitus]. (2016) (0)
Prognostic value of pentraxin 3 in patients with chronic heart failure (2008) (0)
Downward shift of coronary pressure-flow relationship following a brief period of ischemia in dogs. (1995) (0)
A13308 Switching from an angiotensin II receptor blocker to azilsartan improved health-related QOL scores beyond sufficient blood pressure-lowering in patients with uncontrolled hypertension (2018) (0)
Pitavastatin: an overview (2011) (0)
IVUS-Guided PCI: Practical Application (2023) (0)
Threshold of Body Mass Index for the Development of Hypertension Among Japanese Adults. (2022) (0)
P7-1 - Home Medical Care Support for Patients With Left Ventricular Assist Device Using Social Networking Service (2017) (0)
Selective serotonin 5HT2Areceptor inhibition attenuates myocardial ischemia through the increase in nitric oxide production: the alternative role of 5HT1Breceptor (2002) (0)
Clinical Feature of Japanese Patients with Fulminant Myocarditis—Myocarditis in Japanese Patients (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Koichi Node?

Koichi Node is affiliated with the following schools:

Koichi Node's Academic­Influence.com Rankings

Koichi Node's Degrees

Similar Degrees You Can Earn

Why Is Koichi Node Influential?

Koichi Node's Published Works

Published Works

What Schools Are Affiliated With Koichi Node?

Koichi Node's AcademicInfluence.com Rankings